Introduction
Preeclampsia (PE) is a systemic syndrome unique to human pregnancy affecting 5%-12% of all pregnancies (1) . Its pathogenesis is still not fully understood; however, the placenta and the placental bed are implicated as the source. Complex interactions at the maternal/fetal interface lead to deficient placentation and remodeling of spiral arteries (2) . Inadequate uteroplacental perfusion leads to an ischemic placenta with resultant endothelial dysfunction. The hypoxic microenvironment creates an imbalance of circulating angiogenic [vascular endothelial growth factor (VEGF); placental growth factor (PIGF)] and antiangiogenic factors [soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng)] (3). In a recent study, we reported the presence of proand antiangiogenic factors in HIV-associated PE (4) . Additionally, evidence of an exaggerated expression of inflammatory markers in the PE placenta is reported, although the exact role of the placenta in the direct dissemination of inflammatory cytokines remains to be determined (5) .
As early as 1627, Ascillices discovered "milky veins", known today as lymphatic vessels mingled among blood capillaries (6) . Lymphatic vessels transport lymph fluid, proteins, and other cells that leak into tissues from the bloodstream and return them to the circulatory system (7) . Both blood and lymphatic capillaries are lined by a monolayer of endothelial cells of mesodermal origin. The lymphatic system plays a crucial role in tissue fluid homeostasis, immune function, fat metabolism, and transport of proteins and macromolecules and affords protection against viral entry (7) . Impaired lymphatic function is associated with pathological conditions such as lymphedema and hypertension (8) . Recently, an absence of lymphatic vasculature (LYVE-1) in the chorionic villi at term was shown (9) .
Podoplanin (PDPN), also known as T1A, GP36, GP40, Gp38, OTS8, T1A2, TI1A, T1A-2, AGGRUS, HT1A-1, and PA2.26, is a 40-kDa O-linked sialoglycoprotein molecule that is selectively expressed in lymphatic endothelial cells (LECs) but absent in normal vasculature (10) . It is specifically recognized by a novel monoclonal antibody named D2-40, an M r 40,000 O-linked sialoglycoprotein that reacts with a fixation-resistant epitope on the lymphatic endothelium. Podoplanin is regulated by the lymphatic-specific gene Proxy-1, a master gene that controls the development of lymphatic progenitors (11) . Studies have proven podoplanin/D2-40 to be a useful marker in determining lymphatic invasion (12) and demonstrating lymphatic endothelial differentiation (13) .
The presence of placental lymphatics is still under debate (10, 14) . Of note, lymphatic vessels would play a role in maternal and fetal immunity by boosting surveying of the maternal/fetal interface to combat viral infections. HIV-positive women are at increased risk of placental membrane inflammatory lesions (15) such as chorioamnionitis, placental membrane inflammation, and deciduitis (16) . It is plausible to assume that the inflammation caused by HIV infection may be a trigger to enhance lymphangiogenesis in the placenta. Hence, the aim of this study was to evaluate whether PDPN is expressed in term human placentas and to compare its expression in HIV-positive normotensive women and those with PE.
Materials and methods

Study population
The study protocol was approved by the Biomedical Research Ethics Committee of the University of KwaZuluNatal (BE: 040/12). After receiving informed consent, the placenta was obtained from 180 pregnant women immediately after delivery at a large urban regional hospital. The study population consisted of normotensive pregnant (N; n = 60) and preeclamptic (n = 120) women. This group was further stratified based on the gestational age into early onset PE (EOPE; <34 weeks of gestation; n = 60) and late onset PE (LOPE; >34 weeks of gestation; n = 60). Each group was further stratified by HIV status (HIVpositive and HIV-negative; n = 30 each). The groups were thuse categorized as follows: normotensive HIV-negative (N-), normotensive HIV-positive (N+), early onset PE HIV-negative (EOPE-), early onset PE HIV-positive (EOPE+), late onset PE HIV-negative (LOPE-), and late onset PE HIV-positive (LOPE+).
Primigravid and multigravid patients with a diagnosis of PE (new onset blood pressure of ≥140/90 mmHg and at least 1+ proteinuria after 20 gestational weeks) formed the study group. All study participants were delivered by elective cesarean section.
Clinical and demographic data were recorded on a structured data form. Exclusion criteria included chronic hypertension, diabetes, intrauterine death, chorioamnionitis, autoimmune diseases, cardiovascular diseases, and a history of seizures.
Immunohistochemistry
Following delivery of the placenta, a central wedge biopsy was fixed in 10% buffered formaldehyde, dehydrated, and embedded in paraffin wax. Sections (3 µm) were cut on a rotary microtome (Leica RM 2135, Germany) and mounted onto X-tra adhesive coated slides. This was followed by deparaffinization and rehydration in a descending series of ethanol.
Immunostaining was performed using the Dako Envision Flex detection system kit (K800021; Dako, Denmark). Tissue sections were immersed into the preheated target retrieval solution and incubated for 20 min at 97 °C. The slides were then placed in a LINK Autostainer instrument and immunostained using the Envision Flex peroxidase blocking reagent for 5 min and monoclonal mouse antihuman clone D2-40 podoplanin antibody for 20 min. Goat secondary horseradish peroxidase antibody was added for 20 min, followed by 3,3'-diaminobenzidine + chromogen. Sections were counterstained with Mayer's hematoxylin. The lymph node served as a positive control. Replacement of the primary antibody with a buffer or with nonimmune serum of the same IgG class served as a method control and IgG control, respectively. A qualitative evaluation of PDPN immunolocalization was performed.
Morphometric image analysis of podoplanin expression
Placental villi were viewed with an Axioscope A1 microscope (Carl Zeiss, Germany). At least four fields of view per slide for villi type (i.e. conducting and exchange) were randomly selected and archived at an initial objective magnification of 20×. Image capturing, processing, and analysis were performed using AxioVision Image Analysis software (Version 4.8.3, Carl Zeiss, Germany). The percentage of PDPN immunostaining (brown chromogen) within the villi was calculated using the automeasure mode of analysis (9) . Specifically, each conducting villus was framed and the amount of immunostaining was expressed as percentage per frame area. However, within the exchange villi (red), the amount of label (green) was determined by a two-phase threshold and expressed as a total percentage of PDPN within the frame area.
Statistical analysis
GraphPad Prism statistics software, version 5.01 (GraphPad Inc., USA) was used to analyze the data. Descriptive statistics for continuous data are presented by mean ± standard deviation. To determine the statistical difference between study groups, the Kruskal-Wallis test was used for nonparametric data. One-way ANOVA testing was used to examine the effect of HIV infection [HIVpositive (HIV+) vs. HIV-negative (HIV-)], pregnancy type (normotensive vs. preeclamptic), and villus type (exchange vs. conducting) on PDPN immunostaining. P < 0.05 was considered statistically significant.
Results
Patient demographics
Demographics of the study population are shown in the Table. Based on HIV status, a significant difference in maternal age and birth weight was noted in the EOPE group only (P = 0.001 and P = 0.05, respectively).
Podoplanin immunoexpression in placental tissue
Irrespective of the HIV status, villi type, and pregnancy type (normotensive, EOPE, and LOPE), PDPN was strongly immunostained in a reticular-like complex that traversed the mesenchymal stroma around arteries within the conducting (stem) and exchange villi. Based on pregnancy type (normotensive and preeclamptic), PDPN expression was significant in the exchange (P = 0.05) and nonsignificant in the conducting (P = 0.274) villi.
In the exchange villi, the highest percentage of PDPN immunoreactivity was observed in the N+ (19.99 ± 4.02%) and LOPE+ (20.48 ± 3.2%) groups ( Figure 3A ). There was a significant increase of PDPN immunoexpression in the N-vs. N+ and EOPE+ vs. LOPE+ groups (P = 0.004 and P = 0.0001, respectively; Figure 3A) . The PDPN immunoexpression differed significantly among most of the groups ( Figure 3A) .
Within the conducting villi, the N-(9.10 ± 3.18%) and LOPE+ (9.22 ± 3.97%) groups presented the highest PDPN immunoreactivity across all groups ( Figure 3B ). A significant difference in the percentage of PDPN immunoexpression was noted in the N-vs. EOPE+ (P = 0.009) and EOPE+ vs. LOPE+ (P = 0.04) groups. There was an increase in PDPN immunoexpression in the EOPE+ vs. LOPE+ groups (6.45 ± 2.77% vs. 9.22 ± 3.97%; Figure 3B ).
Across pregnancy type (N, EOPE, LOPE)
Based on pregnancy type (normotensive and preeclamptic), the immunoexpression of PDPN was reduced in the preeclamptic compared to the normotensive group (P < 0.03) regardless of HIV status and villi type.
Exchange villi
The immunoexpression of PDPN was significantly elevated between the EOPE and LOPE groups (15.33 ± 4.27% and 17.85 ± 4.74%, respectively; P = 0.04). Although PDPN was high in the normotensive group (18.09 ± 5.61%), it was not significantly different compared to the LOPE group (P = 0.447). The PDPN immunoexpression was lowest within the EOPE group and differed from that of the normotensive group (P = 0.009; Figure 4A ).
Conducting villi
Across pregnancy types (Normotensive 8.31 ± 2.95% vs. EOPE 7.04 ± 3.46% vs. LOPE 8.30 ± 3.45%), PDPN immunoexpressions within the conducting villi were not significantly different ( Figure 4B ).
HIV status (HIV-vs HIV+)
Based on HIV status, the PDPN immunoexpression within exchange villi was significantly different between the HIV+ and HIV-groups (18.06 ± 4.89% and 15.59 ± 4.49%; Figure 5A ) regardless of the pregnancy type. Conversely, PDPN immunoexpression within conducting villi was higher in the HIV-(8.25 ± 3.37%) compared to the HIV+ (7.49 ± 3.23%) group, albeit nonsignificantly (P = 0.142; Figure 5B ). PDPN was upregulated in the HIV+ vs. HIV-groups (11.98 ± 6.48% vs. 10.82 ± 5.66%; P = 0.20) regardless of pregnancy and villi type. The immunoexpression of PDPN was significantly upregulated in the exchange villi (16.99 ± 4.99%; P = 0.001) compared to conducting villi (7.98 ± 3.30%) irrespective of the pregnancy type and HIV status ( Figure 6 ).
Discussion
This study demonstrates an intense reticular-like network of PDPN immunostaining within the mesenchymal stroma of conducting and exchange placental villi. Regardless of HIV status and villi type, the immunoexpression of PDPN was reduced in PE compared to the normotensive group. Our findings are similar to those of Wang et al. (2), who reported a strong expression of PDPN within villous stroma throughout gestation, albeit with a significant reduction in PE compared to normotensive placentas. In contrast, an upregulation of PDPN was reported in inflammatory conditions; PE is a heightened inflammatory state (17) . We propose that the PDPN-rich stromal network within the placental villi may serve as a lymphatic conductive network that maintains the interstitial fluid balance in pregnancy.
It is plausible that the complex reticular-like network of stromal PDPN as observed in our study may be derived from its phylogenetic and progenitor source. These mesenchymal stromal cells are multipotent cells that may differentiate into neurogenic, chondrogenic, osteogenic, adipogenic, and myogenic lineages (18) . We observed that PDPN is expressed in stromal fibroblasts and myofibroblasts. This may be associated with lymphangiogenesis, especially as PDPN is implicated in the lymphatic spread of cancer cells (19) .
In our study, PDPN was absent in vascular endothelial cells. The ontogeny of LECs is debatable. In mammals, the lymphatic endothelial system seems to be exclusively derived from the blood endothelial compartment, as the contribution of hematopoietic cells integrating into lymphatic structures is absent (20) . In contrast, others believe that LECs may have a dual origin, emanating either from embryonic veins or lymphangioblasts (21) .
Podoplanin may play the role of a fluid flux with different phenotypes in perivascular cells and stroma of the placenta (22) . We observed strong immunolocalization of PDPN in the perivascular zone of placental villi. Mesenchymal stem cells may also differentiate into perivascular cells, the precursors of capillary endothelial cells. Fetal blood vessels of stem villi are enclosed by perivascular tissue sheaths, which have abundant α-actin (23) .
In our study, the immunoexpression of PDPN was reduced in PE compared to normotensive pregnancies, irrespective of HIV status and villi type. In normal pregnancy there is a shift from the Th1 to a Th2 immune response; however, this shift is absent in PE (24) . Podoplanin is expressed on the surface of the proinflammatory T cells, Th17 cells, and participates in pregnancy-related pathologies, such as PE and recurrent spontaneous miscarriage (25) .
In acute inflammation, PDPN has an inhibitory function on T-cell response where it controls Th17 response by reducing sensitivity to IL-7 survival signals (26) . It is plausible that PDPN serves to shut off the Th17 response, thereby limiting the pathogenicity of these cells. This action may be mediated through the interaction of PDPN with its three ligands, namely CLEC-2, galectin-8, and the chemokine CCL21 (27) . During acute inflammatory states such as PE, PDPN probably binds to either CLEC-2 or galectin-8, thereby reducing CD4 effector T cells. In the chronic state of HIV infection, PDPN interacts with CCL21 and thus may promote chronic inflammation (26) . In our study, PDPN was upregulated in the HIV+ vs. the HIV-group regardless of pregnancy and villi type. This may be due to the fact that the immune insufficiency of HIV infection is inadequate to neutralize the exaggerated immune response in PE. Alternatively, one should note the fact that all HIV-positive women in our study received antiretroviral therapy. The duration and level of CD4 T-cell counts were, however, not available.
Podoplanin can be integrated into the HIV-1 envelope, thereby influencing HIV-1 infection by interacting with its ligand, CLEC-2, an HIV attachment factor on platelets (28) . The interaction of HIV with CLEC-2 on platelets might induce platelet activation and thrombocytopaenia, which was found to be associated with HIV infection (28) and thus has the potential to control viral expansion.
Early and late PE are thought to reflect different disease conditions, with the former being associated with adverse maternal and neonatal outcomes (29) . In our study, regardless of HIV status, PDPN was downregulated in the EOPE group compared to the LOPE group in the exchange villi. This distribution may reflect the deficient trophoblast invasion that occurred in the EOPE group (29) . In this study, we also noticed high expression of PDPN in the exchange compared to conducting villi. The exchange villi constitute the site of most fetomaternal exchanges and are comparable to alveolar type I cells in the lungs where PDPN has a similar role to that in the placenta (30) . Exchange villi are directly bathed in maternal blood; hence, diffusion occurs directly across this barrier, affecting interstitial fluid accumulation.
While the presence of placental lymphatics is still under debate, we report an absence of regular lymphatic vessels. The presence of a reticular-lymphatic-like conductive network within the placental stroma suggests that this system may be involved in placental fluid homeostasis. We demonstrated an upregulation of PDPN in HIVpositive pregnancies irrespective of the pregnancy type and villi type. However, PDPN immunoexpression was downregulated in the exchange villi of EOPE, reflecting deficient trophoblast invasion. The dual paradigm of the effect of PDPN on T-cell response in HIV infection and pregnancy pathologies differs; hence, the functional role of PDPN via its ligand interaction requires further investigation. 
